Reklama
WIG81 264,27-1,11%
WIG202 398,38-1,09%
EUR / PLN4,32+0,05%
USD / PLN3,99+0,12%
CHF / PLN4,50-0,01%
GBP / PLN5,05+0,00%
EUR / USD1,08-0,08%
DAX17 716,17-0,11%
FT-SE7 640,30-0,55%
CAC 407 956,41+0,28%
DJI38 989,83-0,25%
S&P 5005 130,95-0,12%
ROPA BRENT82,48-0,37%
ROPA WTI78,32-0,56%
ZŁOTO2 115,87+0,07%
SREBRO23,81-0,38%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

SOPHARMA AD: Treasury shares (2023-12-04 14:02)

ESPI | 15:02 04 grudzień 2023

freepik.com
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No201/2023
Date of issue:2023-12-04
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 4, 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 1, 2023 the Company bought 66 000 own shares representing 0.0382% of the share capital of the Company, at a total value of BGN 469 600 on the Bulgarian Stock Exchange, the average price per share was BGN 7,12.
Annexes
FileDescription
Current report_201_buy back_espi.pdfTreasury shares
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2023-12-04Ognian DonevExecutive Director

Masz ciekawy temat? Napisz do nas

Chcesz, żebyśmy opisali Twoją historię albo zajęli się jakimś problemem?

Masz ciekawy temat? Napisz do nas

Napisz do redakcji

Reklama

Czytaj dalej